当前位置: X-MOL 学术BMJ › 论文详情
Inclisiran: UK to roll out new cholesterol lowering drug from next year.
The BMJ ( IF 30.223 ) Pub Date : 2020-01-13 , DOI: 10.1136/bmj.m139
Gareth Iacobucci

The UK government is to launch a major clinical trial of the novel cholesterol lowering drug inclisiran later this year and aims to make it available to NHS patients from 2021.
Inclisiran, an investigational treatment taken by injection twice a year, is a cholesterol lowering therapy in the small interfering RNA (siRNA) class. It has not yet been approved by the US Food and Drug Administration or the European Medicines Agency but is expected to be filed for approval later this year as a preventive add-on treatment to statins for patients who already have a cardiovascular disease diagnosis.
Results of a phase III study of inclisiran involving patients who had elevated LDL cholesterol concentrations despite taking the maximum …
更新日期:2020-01-14

 

全部期刊列表>>
欢迎访问IOP中国网站
GIANT
产业、创新与基础设施
自然科研线上培训服务
材料学研究精选
胸腔和胸部成像专题
屿渡论文,编辑服务
何川
苏昭铭
陈刚
姜涛
李闯创
李刚
北大
跟Nature、Science文章学绘图
隐藏1h前已浏览文章
中洪博元
课题组网站
新版X-MOL期刊搜索和高级搜索功能介绍
ACS材料视界
x-mol收录
上海纽约大学
张健
毛峥伟
陈芬儿
厦门大学
李祥
江浪
张昊
杨中悦
试剂库存
天合科研
down
wechat
bug